← Open Payments lookup

JENNIFER CRIBB: Open Payments

NPI 1093047086 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,336 in 64 payments from 22 companies in 2025. Trend: 2023 $1,258 · 2024 $1,631 · 2025 $1,336

Food & beverage: $1,336
CompanyPaymentsAmount
GlaxoSmithKline, LLC.10$220
PFIZER INC.11$211
Lilly USA, LLC5$168
Boehringer Ingelheim Pharmaceuticals, Inc.5$99
Astellas Pharma US Inc4$81
Novo Nordisk Inc4$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$68
Otsuka America Pharmaceutical, Inc.3$67
ABBVIE INC.3$67
Medtronic, Inc.1$33

Products named: JARDIANCE, NURTEC ODT, TRELEGY ELLIPTA, REXULTI, Veozah, SHINGRIX, CAPLYTA, UBRELVY.

Industry payments across NV — which companies pay providers there.